Banking and financial sector head honchos maintain that the industry ask has consistently been to provide long term capital gains…
A quick back-of-the-envelope calculations by analysts and pharma gurus show ~$8.6B debt at $1.9B EBITDA is 4.5x leverage — it…
The focus of implications would still be around the usual nuances of Indian agriculture since spatial & temporal distribution of…
Central bank may prioritise growth supportive options while tackling imported inflation risks driven by high crude prices and supply chain…
Monetary policy watch: No rate change likely but any CRR/SLR cut will signal huge support for growth
No RBI rate cut is expected at the upcoming MPC meeting, but a CRR or SLR reduction could signal strong…
While NATHEALTH leaders highlight a $1 trillion opportunity in raising India’s Health-Adjusted Life Expectancy (HALE), the industry must first navigate…
Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
Lupin and Zydus partner to co-market semaglutide in India, entering a Rs 1,200 crore market with over 20 competitors and…
Holding ‘half the sky’ at the Bar
The Drug Controller said that the focus is now on stricter quality, faster approvals and future-ready pharma regulation.
In a year from now, progress is to be measured in the institutionalisation of the approach with greater regulatory acceptance…
Infosys co-founder Kris Gopalakrishnan highlights key Budget announcements, including data centre incentives, services-led growth, clean-up measures and support for women…
Bharat Biotech chairman Dr Krishna Ella says employment generation is the central theme of Budget schemes, with major opportunities in…
In the goal to ensure 10 per cent of global services come from India, healthcare could be a huge contributor…
World Health Organisation’s former and first chief scientist Dr Soumya Swaminathan sees the in-house strengthening of CDSCO’s scientific skills and…
The Economic Survey’s FDI roadmap stresses stability and outreach, but economists say faster approvals and simpler processes are crucial to…
It is perhaps time for a national debate and consensus-building on enforcing a fiscal responsibility on transfer payments leading to…
Budget: Expect ‘Jan Vishwas 3.0’, mega multi-year schemes & hope privatisation-backed fiscal probity
Ahead of the Union Budget, industry expects Jan Vishwas 3.0, deregulation, mega multi-year schemes and a renewed push for privatisation…
